alexa
Indianmoney.com Missed Call Number
 
Home News Johnson & Johnson to buy Swiss firm Actelion for $30 billion

Read more interesting news from around the globe with Indianmoney App

Google Play
 
Get the Best Financial Advice on Credit CardClick Here
 
 
Johnson & Johnson to buy Swiss firm Actelion for $30 billion

Johnson & Johnson to buy Swiss firm Actelion for $30 billion

Friday, January 27, 2017, 1:26 PM

US healthcare giant Johnson & Johnson will buy Swiss biotech company Actelion in a $30 billion all-cash deal that includes spinning off Actelion's research and development pipeline, the companies said. The acquisition gives J&J access to the Swiss group's line-up of highprice, high-margin medicines for rare diseases, helping it diversify its drug portfolio as its biggest product, Remicade for arthritis, faces cheaper competition.
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

Get It now!